Bulldog Investors’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bulldog Investors’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,656	Closed	-$1.82M	–	143
2020 Q1	$1.82M	Buy	8,656 +5,941	+219%	+$1.25M	0.96%	34
2019 Q4	$569K	Hold	2,715	–	–	0.24%	86
2019 Q3	$562K	Hold	2,715	–	–	0.25%	78
2019 Q2	$555	Hold	2,715	–	–	0.17%	83
2019 Q1	$547K	Hold	2,715	–	–	0.24%	73
2018 Q4	$533K	Buy	+2,715	New	+$533K	0.2%	80

Other funds holding RVPH

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Bulldog Investors's RVPH Position: Q2 2020 in Review

Bulldog Investors sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2020, closing a stake of 8,656 shares — an estimated $1.82M sold.

Bulldog Investors first reported a position in RVPH in Q4 2018 and held it in 6 quarters. The position peaked at $1.82M in Q1 2020. 16 funds tracked by Wall St. Rank hold RVPH as of Q2 2020.

Bulldog Investors reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2020 after selling out during the quarter.
Bulldog Investors sold 8,656 REVIVA PHARMA HLDGS INC shares in Q2 2020, an estimated $1.82M.
Bulldog Investors first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 6 quarters.
Bulldog Investors's REVIVA PHARMA HLDGS INC position peaked at $1.82M in Q1 2020.
16 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2020.

Based on Bulldog Investors's 13F filing for Q2 2020, filed 13 Aug 2020.